Exploring cognitive impairments and the efficacy of phosphatidylcholine and computer-assisted cognitive training in post-acute COVID-19 and post-acute COVID-19 Vaccination Syndrome
This study examined the impact of PACS/PACVS on cognitive performance and evaluated phosphatidylcholine and CCT as potential treatment options. Patients with PACS/PACVS showed notable cognitive deficits, especially in the domain attention. While the effectiveness of phosphatidylcholine and CCT in treating cognitive deficits was inconclusive, the study indicated the possibility of spontaneous remission of cognitive deficits in PACS/PACVS.
Authors
- Juergen Goller (ORCID: https://orcid.org/0000-0001-8197-279X)
- Udo Zifko
- Muhammad Yacob
- Julian Frederic Hotz
- Sophie Kellerberger
- Sara Elea Jöchlinger
- Iren Danielova
- Hanife Temizsoy
- Sandra Ötsch
Institutions
- Unfallkrankenhaus Meidling (AT)
- Rudolfinerhaus Hospital (AT)
- Hospital of the Brothers of St. John of God (AT)
- Karl Landsteiner University of Health Sciences (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3389/fneur.2024.1419134
- Citations
- 2
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.74